摘要
LMNA基因编码A型和C型核纤层蛋白,参与细胞核核膜的组织,影响基因组稳定性并对细胞分化产生影响。人类肿瘤中LMNA表达异常普遍存在,其突变造成多种核纤层蛋白病,如Emery-Dreifuss肌营养不良症(Emery-Dreifussmusculardystrophy,EDMD)、扩张型心肌病(dilatedcardiomyopathy,DCM)和儿童早老症(Hutchinson-Glifordprogeriasyndrome,HGPS)等。为进一步研究LMNA在细胞内的功能,本研究利用CRISPR/Cas9技术对体外培养的293T与HepG2细胞株的LMNA基因进行编辑,获得两株LMNA基因敲除(LMNA KO)的稳定细胞系。与野生型相比,LMNAKO细胞系增殖能力相对减弱,凋亡增加。同时,细胞形态上也发生显著改变,核膜凹凸不平。本研究首次报道了LMNA KO永生细胞系构建和形态研究结果,为后续LMNA基因功能研究和致病突变体研究奠定基础。
The LMNA gene encodes the nuclear Lamin A and Lamin C proteins,and is related to nuclear membrane organization,genome stability and cell differentiation.Abnormal expression of LMNA is ubiquitous in human tumors,and its mutation leads to various forms of laminopathies,including Emery-Dreifuss muscular dystrophy(EDMD),dilated cardiomyopathy(DCM),and Hutchinson-Gliford progeria syndrome(HGPS).To further determine the functions of the LMNA gene in cellular physiology,the present study used the CRISPR/Cas9 technique to edit the LMNA gene of 293 T and HepG2 cells in vitro,which resulted in two stable LMNA gene knockout(LMNA KO) cell lines.Compared to the respective wild type cells,the LMNA KO cell lines showed decrease in proliferation ability,increase in apoptosis,alteration in cellular morphology and uneven structures in the nucleus membrane.In this study,we report for the first time the results on the construction of LMNA KO immortalized cell lines and characterization of their morphological changes,thereby laying the foundation for the further studies of the LMNA gene functions and pathogenic mutations.
引文
[1]Burke B,Stewart CL.Functional architecture of the cell's nucleus in development,aging,and disease.Curr Top Dev Biol,2014,109:1-52.
[2]Gruenbaum Y,Foisner R.Lamins:Nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation.Annu Rev Biochem,2015,84:131-164.
[3]Gruenbaum Y,Medalia O.Lamins:The structure and protein complexes.Curr Opin Cell Biol,2015,32:7-12.
[4]Swift J,Ivanovska IL,Buxboim A,Harada T,Dingal PCDP,Pinter J,Pajerowski JD,Spinler KR,Shin JW,Tewari M,Rehfeldt F,Speicher DW,Discher DE.Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation.Science,2013,341(6149):1240104.
[5]Davidson PM,Denais C,Bakshi MC,Lammerding J.Nuclear deformability constitutes a rate-limiting step during cell migration in 3-D environments.Cell Mol Bioeng,2014,7(3):293-306.
[6]Kohsaka S,Saito T,Akaike K,Suehara Y,Hayashi T,Takagi T,Kaneko K,Ueno T,Kojima S,Kohashi KI,Mano H,Oda Y,Yao T.Pediatric soft tissue tumor of the upper arm with LMNA-NTRK1 fusion.Hum Pathol,2018,72:167-173.
[7]Sakthivel KM,Sehgal P.A novel role of lamins from genetic disease to cancer biomarkers.Oncol Rev,2016,10(2):309.
[8]Butin-Israeli V,Adam SA,Goldman AE,Goldman RD.Nuclear lamin functions and disease.Trends Genet,2012,28(9):464-471.
[9]Worman HJ,Fong LG,Muchir A,Young SG.Laminopathies and the long strange trip from basic cell biology to therapy.J Clin Invest,2009,119(7):1825-1836.
[10]Gordon LB,Rothman FG,López-Otín C,MisteliT.Progeria:A paradigm for translational medicine.Cell,2014,156(3):400-407.
[11]Gonzalo S,Kreienkamp R.DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome.Curr Opin Cell Biol,2015,34:75-83.
[12]Vidak S,Foisner R.Molecular insights into the premature aging disease progeria.Histochem Cell Biol,2016,145(4):401-417.
[13]Rodríguez S,Eríksson M.Low and high expressing alleles of the LMNA gene:Implications for laminopathy disease development.PLoS One,2011,6(9):e25472.
[14]Vigouroux C,Guénantin AC,Vatier C,Capel E,Le Dour C,Afonso P,Bidault G,Béréziat V,Lascols O,Capeau J,Briand N,Jéru I.Lipodystrophic syndromes due to LMNAmutations:Recent developments on biomolecular aspects,pathophysiological hypotheses and therapeutic perspectives.Nucleus,2018,9(1):251-264.
[15]Cenni V,D'Apice MR,Garagnani P,Columbaro M,Novelli G,Franceschi C,Lattanzi G.Mandibuloacral dysplasia:Apremature ageing disease with aspects of physiological ageing.Ageing Res Rev,2018,42:1-13.
[16]Al-Saaidi R,Bross P.Do lamin A and lamin C have unique roles?Chromosoma,2015,124(1):1-12.
[17]Young SG,Jung HJ,Lee JM,Fong LG.Nuclear lamins and neurobiology.Mol Cell Biol,2014,34(15):2776-2785.
[18]Jahn D,Schramm S,Schn?lzer M,Heilmann CJ,de Koster CG,Schutz W,Benavente R,Alsheimer M.A truncated lamin A in the Lmna-/-mouse line:Implications for the understanding of laminopathies.Nucleus,2012,3(5):463-474.
[19]Capell BC,Collins FS.Human laminopathies:Nuclei gone genetically awry.Nat Rev Genet,2006,7(12):940-952.
[20]Camozzi D,Capanni C,Cenni V,Mattioli W,Columbaro M,Squarzoni S,Lattanzi G.Diverse lamin-dependent mechanisms interact to control chromatin dynamics.Focus on laminopathies.Nucleus,2014,5(5):427-440.
[21]Bertrand AT,Chikhaoui K,Yaou RB,Bonne G.Clinical and genetic heterogeneity in laminopathies.Biochem Soc Trans,2011,39(6):1687-1692.
[22]Smith ED,Kudlow BA,Frock RL,Kennedy BK.A-type nuclear lamins,progerias and other degenerative disorders.Mech Ageing Dev,2005,126(4):447-460.
[23]Manju K,Muralikrishna B,Parnaik VK.Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci.J Cell Sci,2006,119(Pt 13):2704-2714.
[24]Ul Ain Q,Chung JY,Kim YH.Current and future delivery systems for engineered nucleases:ZFN,TALEN and RGEN.J Control Release,2015,205:120-127.
[25]Zheng W,Gu F.Progress of application and off-target effects of CRISPR/Cas9.Hereditas(Beijing),2015,37(10):1003-1010.郑武,谷峰.CRISPR/Cas9的应用及脱靶效应研究进展.遗传,2015,37(10):1003-1010.
[26]Paquet D,Kwart D,Chen A,Sproul A,Jacob S,Teo S,Olsen KM,Gregg A,Noggle S,Tessier-Lavigne M.Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.Nature,2016,533(7601):125-129.
[27]Miyaoka Y,Berman JR,Cooper SB,Mayerl SJ,Chan AH,Zhang B,Karlin-Neumann GA,Conklin BR.Systematic quantification of HDR and NHEJ reveals effects of locus,nuclease,and cell type on genome-editing.Sci Rep,2016,6:23549.
[28]Liu DY,Qiu T,Ding XH,Li M,Zhu MY,Wang JH.Rapid construction of multiple sgRNA vectors and knockout of the Arabidopsis IAA2 gene using the CRISPR/Cas9genomic editing technology.Hereditas(Beijing),2016,38(8):756-764.刘丁源,邱婷,丁晓辉,李苗苗,朱睦元,王君晖.快速构建多重sgRNA载体利用CRISPR/Cas9技术敲除拟南芥IAA2基因.遗传,2016,38(8):756-764.
[29]Graziano S,Kreienkamp R,Coll-Bonfill N,Gonzalo S.Causes and consequences of genomic instability in laminopathies:Replication stress and interferon response.Nucleus,2018,9(1):289-306.
[30]Rauschert I,Aldunate F,Preussner J,Arocena-Sutz M,Peraza V,Looso M,Benech JC,Agrelo R.Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.PLoS One,2017,12(4):e0175953.
[31]Tariq Z,Zhang H,Chia-Liu A,Shen Y,Gete Y,Xiong ZM,Tocheny C,Campanello L,Wu D,Losert W,Cao K.Lamin A and microtubules collaborate to maintain nuclear morphology.Nucleus,2017,8(4):433-446.
[32]Dahl KN,Kahn SM,Wilson KL,Discher DE.The nuclear envelope lamina network has elasticity and a compressibility limit suggestive of a molecular shock absorber.J Cell Sci,2004,117(Pt 20):4779-4786.
[33]Reddy S,Comai L.Recent advances in understanding the role of lamins in health and disease.F1000Res,2016,5:2536.
[34]Liu GH,Barkho BZ,Ruiz S,Diep D,Qu J,Yang SL,Panopoulos AD,Suzuki K,Kurian L,Walsh C,Thompson J,Boue S,Fung HL,Sancho-Martinez I,Zhang K,Yates J3rd,Izpisua Belmonte JC.Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.Nature,2011,472(7342):221-225.
[35]Denais CM,Gilbert RM,Isermann P,McGregor AL,te Lindert M,Weigelin B,Davidson PM,Friedl P,Wolf K,Lammerding J.Nuclear envelope rupture and repair during cancer cell migration.Science,2016,352(6283):353-358.
[36]Harada T,Swift J,Irianto J,Shin JW,Spinler KR,Athirasala A,Diegmiller R,Dingal PCDP,Ivanovska IL,DischerDE.Nuclear lamin stiffness is a barrier to 3Dmigration,but softness can limit survival.J Cell Biol,2014,204(5):669-682.
[37]Bell ES,Lammerding J.Causes and consequences of nuclear envelope alterations in tumour progression.Eur JCell Biol,2016,95(11):449-464.
